214 related articles for article (PubMed ID: 25712221)
21. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
[TBL] [Abstract][Full Text] [Related]
22. Substrate and cofactor requirements of indoleamine 2,3-dioxygenase in interferon-gamma-treated cells: utilization of oxygen rather than superoxide.
Werner ER; Werner-Felmayer G
Curr Drug Metab; 2007 Apr; 8(3):201-3. PubMed ID: 17430107
[TBL] [Abstract][Full Text] [Related]
23. Fully automated radiosynthesis of N(1)-[(18)F]fluoroethyl-tryptophan and study of its biological activity as a new potential substrate for indoleamine 2,3-dioxygenase PET imaging.
Henrottin J; Lemaire C; Egrise D; Zervosen A; Van den Eynde B; Plenevaux A; Franci X; Goldman S; Luxen A
Nucl Med Biol; 2016 Jun; 43(6):379-89. PubMed ID: 27260779
[TBL] [Abstract][Full Text] [Related]
24. Ligand and substrate migration in human indoleamine 2,3-dioxygenase.
Nickel E; Nienhaus K; Lu C; Yeh SR; Nienhaus GU
J Biol Chem; 2009 Nov; 284(46):31548-54. PubMed ID: 19767648
[TBL] [Abstract][Full Text] [Related]
25. The ternary complex of PrnB (the second enzyme in the pyrrolnitrin biosynthesis pathway), tryptophan, and cyanide yields new mechanistic insights into the indolamine dioxygenase superfamily.
Zhu X; van Pée KH; Naismith JH
J Biol Chem; 2010 Jul; 285(27):21126-33. PubMed ID: 20421301
[TBL] [Abstract][Full Text] [Related]
26. Exploring a repurposed candidate with dual hIDO1/hTDO2 inhibitory potential for anticancer efficacy identified through pharmacophore-based virtual screening and in vitro evaluation.
Aboomar NM; Essam O; Hassan A; Bassiouny AR; Arafa RK
Sci Rep; 2024 Apr; 14(1):9386. PubMed ID: 38653790
[TBL] [Abstract][Full Text] [Related]
27. Reassessment of the reaction mechanism in the heme dioxygenases.
Chauhan N; Thackray SJ; Rafice SA; Eaton G; Lee M; Efimov I; Basran J; Jenkins PR; Mowat CG; Chapman SK; Raven EL
J Am Chem Soc; 2009 Apr; 131(12):4186-7. PubMed ID: 19275153
[TBL] [Abstract][Full Text] [Related]
28. Human tryptophan dioxygenase: a comparison to indoleamine 2,3-dioxygenase.
Batabyal D; Yeh SR
J Am Chem Soc; 2007 Dec; 129(50):15690-701. PubMed ID: 18027945
[TBL] [Abstract][Full Text] [Related]
29. Evidence for a ferryl intermediate in a heme-based dioxygenase.
Lewis-Ballester A; Batabyal D; Egawa T; Lu C; Lin Y; Marti MA; Capece L; Estrin DA; Yeh SR
Proc Natl Acad Sci U S A; 2009 Oct; 106(41):17371-6. PubMed ID: 19805032
[TBL] [Abstract][Full Text] [Related]
30. Complete reaction mechanism of indoleamine 2,3-dioxygenase as revealed by QM/MM simulations.
Capece L; Lewis-Ballester A; Yeh SR; Estrin DA; Marti MA
J Phys Chem B; 2012 Feb; 116(4):1401-13. PubMed ID: 22196056
[TBL] [Abstract][Full Text] [Related]
31. Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase.
Rafice SA; Chauhan N; Efimov I; Basran J; Raven EL
Biochem Soc Trans; 2009 Apr; 37(Pt 2):408-12. PubMed ID: 19290871
[TBL] [Abstract][Full Text] [Related]
32. Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO).
Macchiarulo A; Nuti R; Bellocchi D; Camaioni E; Pellicciari R
Biochim Biophys Acta; 2007 Aug; 1774(8):1058-68. PubMed ID: 17644054
[TBL] [Abstract][Full Text] [Related]
33. 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).
Saito K; Chen CY; Masana M; Crowley JS; Markey SP; Heyes MP
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):11-4. PubMed ID: 8471029
[TBL] [Abstract][Full Text] [Related]
34. Tracking Hidden Binding Pockets Along the Molecular Recognition Path of l-Trp to Indoleamine 2,3-Dioxygenase 1.
Greco FA; Albini E; Coletti A; Dolciami D; Carotti A; Orabona C; Grohmann U; Macchiarulo A
ChemMedChem; 2019 Dec; 14(24):2084-2092. PubMed ID: 31724832
[TBL] [Abstract][Full Text] [Related]
35. Role of indoleamine 2,3-dioxygenase in health and disease.
Yeung AW; Terentis AC; King NJ; Thomas SR
Clin Sci (Lond); 2015 Oct; 129(7):601-72. PubMed ID: 26186743
[TBL] [Abstract][Full Text] [Related]
36. Structural insights into substrate and inhibitor binding sites in human indoleamine 2,3-dioxygenase 1.
Lewis-Ballester A; Pham KN; Batabyal D; Karkashon S; Bonanno JB; Poulos TL; Yeh SR
Nat Commun; 2017 Nov; 8(1):1693. PubMed ID: 29167421
[TBL] [Abstract][Full Text] [Related]
37. Ligand migration in human indoleamine-2,3 dioxygenase.
Nienhaus K; Nickel E; Lu C; Yeh SR; Nienhaus GU
IUBMB Life; 2011 Mar; 63(3):153-9. PubMed ID: 21445845
[TBL] [Abstract][Full Text] [Related]
38. Probing the ternary complexes of indoleamine and tryptophan 2,3-dioxygenases by cryoreduction EPR and ENDOR spectroscopy.
Davydov RM; Chauhan N; Thackray SJ; Anderson JL; Papadopoulou ND; Mowat CG; Chapman SK; Raven EL; Hoffman BM
J Am Chem Soc; 2010 Apr; 132(15):5494-500. PubMed ID: 20353179
[TBL] [Abstract][Full Text] [Related]
39. Human indoleamine 2,3-dioxygenase is a catalyst of physiological heme peroxidase reactions: implications for the inhibition of dioxygenase activity by hydrogen peroxide.
Freewan M; Rees MD; Plaza TS; Glaros E; Lim YJ; Wang XS; Yeung AW; Witting PK; Terentis AC; Thomas SR
J Biol Chem; 2013 Jan; 288(3):1548-67. PubMed ID: 23209301
[TBL] [Abstract][Full Text] [Related]
40. Methylene blue and ascorbate interfere with the accurate determination of the kinetic properties of IDO2.
Yuasa HJ; Stocker R
FEBS J; 2021 Aug; 288(16):4892-4904. PubMed ID: 33686747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
